Company Description
BioHarvest Sciences Inc. operates as a biotechnology company.
The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.
The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals.
It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products.
Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes.
The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
| Country | Canada |
| Founded | 2007 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 2 |
| CEO | Ilan Sobel |
Contact Details
Address: 1140-625 Howe Street Vancouver, BC V6C 2T6 Canada | |
| Phone | (604) 622-1186 |
| Website | bioharvest.com |
Stock Details
| Ticker Symbol | BHST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001723464 |
| ISIN Number | CA09076J2074 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ilan Sobel | Chief Executive Officer |
| Dr. Zaki Rakib Ph.D. | Co-Founder, Executive Chairman and President |
| Dr. Yochi Hagay Ph.D. | Co-Founder, Chief Technology Officer and Member of Scientific Advisory Board |
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| David K. Ryan | Vice President of Investor Relations and Secretary |
| Dr. Brian S. Cornblatt | Chief Medical Officer and Member of Scientific Advisory Board |
| Bar Dichter | Chief Financial Officer |
| Matthew Joseph Zrebiec | Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2025 | 6-K | Report of foreign issuer |
| Apr 1, 2025 | 6-K | Report of foreign issuer |
| Mar 31, 2025 | F-X | Filing |
| Mar 31, 2025 | 40-F | Filing |
| Mar 17, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Mar 4, 2025 | 6-K | Report of foreign issuer |
| Feb 18, 2025 | 6-K | Report of foreign issuer |
| Feb 14, 2025 | 6-K | Report of foreign issuer |
| Feb 12, 2025 | SCHEDULE 13G | Filing |